Pathos AI partners with Bristol Myers Squibb and Tempus AI to advance drug development

HealthcareLdr · x · 2026-10-25

Pathos AI announced a partnership with Bristol Myers Squibb and Tempus AI to advance drug development with AI. The post is a link share without further deal details.

Original post →

More from Companies & People

Companies & People channel →